Citing enrollment challenges, Bristol Myers and 2seventy scrap Abecma trial in first-line myeloma

0

25.09.2024 17:23

Fiercepharma.com

Citing enrollment challenges, Bristol Myers and 2seventy scrap Abecma trial in first-line myeloma aliu Wed, 09/25/2024 - 10:23